|
KMID : 0923620150150020100
|
|
Immune Network
2015 Volume.15 No. 2 p.100 ~ p.109
|
|
|
1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) Modulates Th2 Immunity through Attenuation of IL-4 Expression
|
|
:Yoon Sun-Young
:Sohn Ki-Young/:Han Yong-Hae/:Chong Sae-ho/:Kang Ho-Bum/:Ko Young-Eun/:Shin Su-Hyun/:Kim Young-Jun/:Kim Jae-Wha
|
|
|
Abstract
|
|
|
|
Controlling balance between T-helper type 1 (Th1) and T-helper type 2 (Th2) plays a pivotal role in maintaining the biological rhythm of Th1/Th2 and circumventing diseases caused by Th1/Th2 imbalance. Interleukin 4 (IL-4) is a Th2-type cytokine and often associated with hypersensitivity-related diseases such as atopic dermatitis and allergies when overexpressed. In this study, we have tried to elucidate the function of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) as an essential modulator of Th1/Th2 balance. EC-18 has showed an inhibitory effect on the production of IL-4 in a dose-dependent manner. RT-PCR analysis has proved EC-18 affect the transcription of IL-4. By analyzing the phosphorylation status of Signal transducer and activator of transcription 6 (STAT6), which is a transcriptional activator of IL-4 expression, we discovered that EC-18 induced the decrease of STAT6 activity in several stimulated cell lines, which was also showed in STAT6 reporter analysis. Co-treatment of EC-18 significantly weakened atopy-like phenotypes in mice treated with an allergen. Collectively, our results suggest that EC-18 is a potent Th2 modulating factor by regulating the transcription of IL-4 via STAT6 modulation, and could be developed for immune-modulatory therapeutics.
|
|
|
KEYWORD
|
|
|
EC-18, Th2 modulator, IL-4, STAT6
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|